Add to ORKGcedes acute myocardial infarction (AMI)6 is associated with changes in human serum albumin (HSA) that result in decreased divalent cobalt ion (Co2) binding. This reaction the basis of the serum colorimetric Co2-HSA binding assay, which is an indirect mea-sure of ischemia-modified albu-min (IMA). Previously we showed that IMAwas a useful diagnostic test for the diagnosis of myocardial isch-emia in suspected acute coronary syndromes (ACS) patients (are
The search for a suitable and reliable marker of myocardial ischemia has led to the proposal of empl...
BACKGROUND: Ischemic heart disease is the greatest single cause of mortality and loss of disability...
Background: Diagnosis of acute coronary syndrome (ACS) is important, due to the associated very high...
WOS: 000398714300001PubMed ID: 28356609Ischemia-modified albumin (IMA) is assumed "N-terminal modifi...
Introduction: Acute myocardial infarction (AMI) is still one of the most common causes of death worl...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
We studied the role of ischemia-modified albumin (IMA) with standard biomarkers (myoglobin, creatine...
This work was supported by the Leverhulme Trust (grant ref. RPG-2017-214), BBSRC (grant ref. BB/J006...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Abstract. Ischemia modified albumin (IMA) is a relatively new marker for evaluating patients with ca...
The search for a suitable and reliable marker of myocardial ischemia has led to the proposal of empl...
BACKGROUND: Ischemic heart disease is the greatest single cause of mortality and loss of disability...
Background: Diagnosis of acute coronary syndrome (ACS) is important, due to the associated very high...
WOS: 000398714300001PubMed ID: 28356609Ischemia-modified albumin (IMA) is assumed "N-terminal modifi...
Introduction: Acute myocardial infarction (AMI) is still one of the most common causes of death worl...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical mar...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
We studied the role of ischemia-modified albumin (IMA) with standard biomarkers (myoglobin, creatine...
This work was supported by the Leverhulme Trust (grant ref. RPG-2017-214), BBSRC (grant ref. BB/J006...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Recent studies have suggested that heart-type fatty acid-binding protein (H-FABP) may detect ongoing...
Abstract. Ischemia modified albumin (IMA) is a relatively new marker for evaluating patients with ca...
The search for a suitable and reliable marker of myocardial ischemia has led to the proposal of empl...
BACKGROUND: Ischemic heart disease is the greatest single cause of mortality and loss of disability...
Background: Diagnosis of acute coronary syndrome (ACS) is important, due to the associated very high...